NEW YORK–(BUSINESS WIRE) — Gameto, a pioneering biotechnology company focused on advancing women’s health treatments, announced today the successful birth of the world’s first baby conceived through Fertilo, an innovative ovarian support cell (OSC) technology that matures eggs outside the body. The historic delivery took place at Santa Isabel Clinic in Lima, Peru.
Fertilo marks a significant advancement in assisted reproductive technology (ART), offering an alternative to traditional in vitro fertilization (IVF). Conventional IVF protocols require 10-14 days of high-dose hormonal stimulation to mature eggs, a process that can cause discomfort and risks for patients. By contrast, Fertilo utilizes engineered, young ovarian support cells to replicate natural egg maturation in a laboratory setting, reducing hormonal injections by 80% and shortening treatment cycles to just three days.
“We are delighted to celebrate the world’s first live birth conceived using Fertilo,” said Dr. Dina Radenkovic, CEO and co-founder of Gameto. “By addressing the challenges of conventional IVF, including lengthy cycles, severe side effects, and emotional strain, Fertilo offers a faster, safer, and less invasive solution. This milestone highlights the transformative potential of iPSC technology in IVF and marks a turning point in reproductive medicine.”
This achievement demonstrates the first successful use of an end-to-end therapy developed from induced pluripotent stem cells (iPSC) to improve IVF outcomes. In clinical settings, co-culturing immature eggs with Gameto’s proprietary OSCs has shown promising results, with improved rates of egg maturation and embryo formation.
Dr. Luis Guzmán, Lead at Pranor Labs & Science, who oversaw the groundbreaking IVF cycle, emphasized the benefits of this technology. “The ability to mature eggs outside the body with minimal hormonal intervention significantly reduces risks like ovarian hyperstimulation syndrome while alleviating the side effects of hormone doses. Fertilo represents a major advancement for women who cannot tolerate or prefer to avoid the burdens of traditional IVF protocols, offering hope to a broader patient population.”
The mother of the first baby born through Fertilo expressed gratitude for the innovative approach. “With fewer injections and a gentler egg retrieval process, Fertilo gave me hope and reassurance during my journey. It made the physical and emotional experience significantly easier, and I am profoundly thankful to the Pranor Clinic and Gameto team for helping me achieve my dream of having a family.”
By reducing hormonal stimulation and maturing eggs outside the body, Gameto’s Fertilo enhances both outcomes and patient experiences in assisted reproduction. The process delivers high-quality, mature eggs with similar efficacy to traditional IVF while minimizing complications and emotional strain.
Related topics:
Women-Led Fertility Startup Lushi Redefines IVF Journey for American Women
IVF Offers New Hope for Parenthood to HIV-Positive Individuals
Samantha Ruth Prabhu Embraces Positivity Amid Personal and Professional Milestones
